Mouse Anti-CD164 Recombinant Antibody (CBFYC-0298) (CBMAB-C0331-FY)

Watt, S. M., Bühring, H. J., Simmons, P. J., & Zannettino, A. W. (2021). The stem cell revolution: on the role of CD164 as a human stem cell marker. NPJ Regenerative Medicine, 6(1), 1-6.

Mancarella, C., Caldoni, G., Ribolsi, I., Parra, A., Manara, M. C., Mercurio, A. M., ... & Scotlandi, K. (2020). Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis. Frontiers in Oncology, 10, 994.

Zhang, L., Wang, Y., & Su, H. (2020). Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway. Neoplasma, 67(4), 762-772.

Wang, C. C., Hueng, D. Y., Huang, A. F., Chen, W. L., Huang, S. M., & Chan, J. Y. H. (2019). CD164 regulates proliferation, progression, and invasion of human glioblastoma cells. Oncotarget, 10(21), 2041.

Mancarella, C., Manara, M. C., Mercurio, A. M., & Scotlandi, K. (2019). Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3-mediated regulation of CD164-CXCR4 axis impacts aggressiveness of Ewing sarcoma.

Tu, M., & Zheng, W. (2018). CD164 induced the apoptosis of U87 cell by down-regulating PTEN/PI3K/AKT signal pathway in vitro.

Chen, W. L., Huang, A. F., Huang, S. M., Ho, C. L., Chang, Y. L., & Chan, J. Y. H. (2017). CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt/mTOR signaling. Oncotarget, 8(33), 54115.

Tu, M., Cai, L., Zheng, W., Su, Z., Chen, Y., & Qi, S. (2017). CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma. Molecular medicine reports, 15(4), 1713-1721.

Benoit, B. M., Jariwala, N., O’Connor, G., Oetjen, L. K., Whelan, T. M., Werth, A., ... & Wysocka, M. (2017). CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214. Archives of dermatological research, 309(1), 11-19.

Chen, J. H., Chen, W. L., Chan, J. Y. H., Chen, Y. W., Peng, Y. J., Cheng, M. F., & Lin, C. S. (2017). Overexpression of CD164 in oral cavity squamous cell carcinoma predicts a favourable prognosis. Oncology letters, 14(5), 6103-6108.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols